Freedom Capital upgraded AngioDynamics to strong-buy, while MarketBeat reported the company's average rating.
1 report, 1 independent
Updated Jul 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Freedom Capital upgraded AngioDynamics to strong-buy, while MarketBeat reported the company's average rating.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Freedom Capital
company in the Czech Republic
-
MarketBeat
American personal finance blog